免疫学
免疫系统
医学
免疫球蛋白E
细胞因子
过敏性炎症
细胞内
过敏反应
免疫病理学
信号转导
获得性免疫系统
先天免疫系统
过敏
长时程增强
胸腺基质淋巴细胞生成素
T细胞
细胞信号
生物
白细胞介素13
免疫耐受
生物信息学
白细胞介素4
先天性淋巴细胞
炎症
细胞
免疫疗法
神经科学
过敏性哮喘
作者
Li Tian,Juanjuan Li,Yun Hu,Mengdi Li,Ruyu Niu,苏莉斯,Peng Zhang,Xianhai Zeng
标识
DOI:10.1096/fj.202600205r
摘要
Allergic diseases, including pathologies such as allergic rhinitis, asthma, atopic dermatitis, and food allergies, are fundamentally driven by aberrant immunoglobulin E (IgE) production and pronounced T helper 2 (Th2) cell responses. The escalating global prevalence of these conditions represents a substantial public health challenge, stimulating intensive research into novel therapeutic vulnerabilities. Interleukin-18 (IL-18), a pleiotropic cytokine operating at the interface of innate and adaptive immunity, has emerged as a key modulator in this context. While classically associated with augmenting interferon-γ (IFN-γ) production by Th1 cells, IL-18 paradoxically promotes the maturation and functional potentiation of mast cells and basophils, particularly in synergy with IL-2, thereby contributing mechanistically to the immunopathology of allergic inflammation. The bioactivity of IL-18 is contingent upon proteolytic processing, and the precise molecular pathways through which it orchestrates allergic responses remain under active investigation. This review comprehensively synthesizes the current understanding of IL-18 biology, detailing its cellular origins, activation mechanisms, and intracellular signaling cascades. Furthermore, we critically evaluate the multifaceted impact of IL-18 on key immune cell subsets involved in allergic hypersensitivity and discuss the rationale and potential for therapeutic interventions targeting the IL-18 axis in the management of allergic diseases.
科研通智能强力驱动
Strongly Powered by AbleSci AI